London: Weight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as SoftBank and Mubadala ...

The funding participants include F-Prime Capital, GV, Mubadala Capital, Newpath Partners, SoftBank Vision Fund 2 and other undisclosed investors. Meanwell served as the CEO of The Medicines ...

Gulf Warehousing Company (GWC) has unveiled its latest initiative by integrating vision-picking technology into supply chain operations. “With a steadfast commitment to innovation, GWC is the ...

Investors included 1kx, Lattice, founders from Japanese e-commerce company Mercari and web3 company Cega, angel investors like CDO at Rakuten, and the head of investment at SoftBank Vision Fund. Des ...

City officials will host a public open house regarding the next steps in the Vision Fund process. The open house will be held Monday, April 29 from 5 to 6:30 p.m. in the Circle of Friends ...

NEW YORK (Reuters) - SoftBank Group Corp has acquired the 25% stake in Arm Ltd it does not directly own from its Vision Fund unit in a deal that values the chip designer at $64 billion ...

And yet, that’s just where we are with the Apple Vision Pro and similar products. I’m not declaring that the Vision Pro has a special destiny because there’s no way to know that. But I do ...

Cohesity’s current marquee investors, including Softbank Vision Fund, Sequoia Capital, Wing Venture Capital and Premji Invest, will continue to support the combined entity. Existing Veritas ...

SCG Asset Management LLC (“SCGAM”), a provider of derivative-based investment solutions, today announced that Vision 4 Fund Distributors, LLC (“Vision 4”) will provide third-party sales ...

Meanwhile, the eyewear company is reportedly likely to go public soon. SoftBank Vision Fund managing partner and chief financial officer Navneet Govil had said in an interview that Lenskart ...

The company last announced its Series C raise in 2022, led by SoftBank Vision Fund 2 for $115 million, valuing the company at $575 million. Platform Science has raised $309 million since 2017.